The price of Rinvoq (upadacitinib) can vary significantly based on factors such as dosage, quantity, insurance coverage, and pharmacy. Information from GoodRx indicates that the average retail price for a 30-day supply of Rinvoq 15 mg extended-release tablets is approximately $6,000 to $7,000 [1]. However, with coupons, the price can be reduced to around $5,000 to $6,000 [1].
What factors influence Rinvoq's cost?
The cost of Rinvoq is influenced by several elements, including the specific formulation and strength of the medication, the number of tablets prescribed, and the patient's insurance plan. Manufacturers also offer patient assistance programs that can help reduce out-of-pocket expenses for eligible individuals [2].
How can I find lower prices for Rinvoq?
Patients seeking more affordable options for Rinvoq can explore various avenues. Utilizing discount cards and coupons from sources like GoodRx can significantly lower the retail price [1]. Additionally, inquiring about manufacturer assistance programs or checking prices at different pharmacies may yield savings.
When does Rinvoq's patent expire?
The patent landscape for Rinvoq is complex, with multiple patents covering different aspects of the drug. According to DrugPatentWatch.com, key patents related to Rinvoq's composition of matter and methods of use have expiration dates extending into the late 2030s and beyond [3]. These patents are crucial for protecting the drug from generic competition, and their expiration dates will determine when biosimilar versions could potentially enter the market.
What are the approved uses for Rinvoq?
Rinvoq is an FDA-approved medication used to treat a range of inflammatory conditions. Its approved indications include rheumatoid arthritis, psoriatic arthritis, ankylosing spondylitis, atopic dermatitis, ulcerative colitis, and Crohn's disease [4]. The specific indication can sometimes influence treatment protocols and, consequently, costs.
Who manufactures Rinvoq?
Rinvoq is manufactured by AbbVie Inc. [4]. AbbVie is a biopharmaceutical company that develops and markets a variety of therapeutic drugs.
What are the potential side effects of Rinvoq?
Like many medications, Rinvoq carries potential side effects. Common side effects include upper respiratory tract infections, nausea, cough, fever, and acne [4]. More serious side effects can involve an increased risk of serious infections, blood clots, heart attack, stroke, certain cancers, and changes in cholesterol levels [4]. Patients should discuss any concerns about side effects with their healthcare provider.
How does Rinvoq work?
Rinvoq is a Janus kinase (JAK) inhibitor. It works by blocking the activity of specific JAK enzymes, which are involved in the signaling pathways that lead to inflammation in the body [4]. By reducing this inflammation, Rinvoq can help alleviate symptoms associated with various autoimmune and inflammatory diseases.
---
Sources
[1] GoodRx. (n.d.). Rinvoq Prices, Coupons, and Patient Assistance Programs. Retrieved from https://www.goodrx.com/rinvoq
[2] AbbVie. (n.d.). Rinvoq Patient Support. Retrieved from https://www.rxabbvie.com/patients/rinvoq/support.html
[3] DrugPatentWatch.com. (n.d.). Rinvoq (upadacitinib) Drug Patent Information. (Note: Specific patent details and expiration dates are subject to change and require direct access to DrugPatentWatch.com for precise information).
[4] U.S. Food and Drug Administration. (n.d.). Rinvoq Prescribing Information. Retrieved from https://www.fda.gov/drugsatfda/labeling/drug-label-information (Note: Direct links to specific drug labels can be found via the FDA's drug database).